Loading...
OTCM
EHSI
Market cap21mUSD
Jun 29, Last price  
1.01USD
Name

US Neurosurgical Holdings Inc

Chart & Performance

D1W1MN
OTCM:EHSI chart
P/E
—
P/S
21.12
EPS
—
Div Yield, %
—
Shrs. gr., 5y
23.75%
Rev. gr., 5y
-20.24%
Revenues
1m
2,002,0001,638,0001,751,0002,261,0002,557,0002,060,0001,956,000-30,0002,607,0002,971,0003,212,0003,414,0003,424,0003,070,0003,173,0001,061,0000001,024,000
Net income
-8m
L+279.76%
-383,000-335,0004,00072,000469,00029,000729,000-667,000561,000396,000536,000538,000-421,000142,000533,000-881,000-1,572,000-816,000-2,055,000-7,804,000
CFO
-3m
L+94.06%
535,000501,000668,000715,0001,288,000648,000861,000-980,000951,0001,158,0001,361,0002,348,0002,288,0001,547,0001,117,000174,000-1,413,000-891,000-1,515,000-2,940,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

U.S. NeuroSurgical Holdings, Inc. oversees and operates specialized facilities for stereotactic radiosurgery, leveraging gamma knife technology. This gamma knife system functions as a precise, non-invasive radiosurgical instrument, effectively treating brain tumors and various cerebral malformations. The company, which originated in 1993, maintains its principal office in Rockville, Maryland.
URL
https://www.usneuro.com
IPO date
Oct 21, 1999
Employees
3
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT